Kaynes Tech Dips 6% Post Lock-In, 11.6M Shares Free
Kaynes Technology India shares fell nearly 6% as lock-in period ended, freeing 11.6M shares worth ₹7,233 crore. Company shows strong Q2 growth with profit up 102%. Read analysis.
Category : Search result: semaglutide patent expiry
Apple Watch Faces New US Import Ban Threat
US ITC investigates Apple's redesigned blood oxygen feature. Potential import ban on Series 9, Series 10 & Ultra 2 watches could disrupt holiday sales. Latest update on $634M patent battle.
Chandigarh Students Patent Innovative Medical Device
Students from Chandigarh's Satluj School secure patent for portable medical device. Learn how this innovation addresses critical healthcare challenges in remote areas.
Ajay Devgn, Kajol debate love and marriage longevity
Ajay Devgn says unconditional love exists only for pets, while wife Kajol believes marriages need expiry dates. Read about their contrasting views on modern relationships.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
SEBI Approves Weekly F&O Expiry, Tightens Short Selling Rules
India's market regulator SEBI announces major reforms in short selling framework, introducing weekly expiry F&O contracts, mandatory securities lending, and stricter disclosure norms for investors.
White House Deal Cuts Ozempic & Wegovy Prices in India
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Trump's $149 Weight-Loss Drug Deal with Ozempic Maker
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
Adeia Sues AMD Over Technology Licensing Dispute
US technology firm Adeia sues AMD for alleged patent infringement, demanding fair licensing terms for semiconductor innovations. Get the full story on this major tech legal battle.
Viral Molecule Weight Loss Pills: Experts Warn Russians
Discover why molecule-based weight loss supplements are going viral among young Russians. Learn about the science, risks, and expert warnings about this concerning health trend.
FDA Approves Oral Weight Loss Drug Rybelsus
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
GLP-1 Drugs: How Ozempic & Mounjaro Work
Discover how GLP-1 receptor agonists are revolutionizing diabetes and obesity treatment. Learn the mechanism behind popular drugs like Ozempic, Mounjaro, and other game-changing medications.
Samsung's Tri-Folding Phone: World's Slimmest Foldable?
Samsung is developing a revolutionary tri-folding smartphone that could become the slimmest foldable device ever, potentially beating the upcoming Galaxy Z Fold 7 in both innovation and design.
Perplexity AI Launches Revolutionary Patent Research Tool
Perplexity AI CEO Aravind Srinivas unveils revolutionary AI-powered patent research tool that transforms how innovators search and analyze patents with natural language queries.
Weight Loss Shots: Bengaluru Doctors Issue Warning
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.
Apple Demands OPPO Fire Engineers in Patent Battle
Tech giant Apple escalates legal war against OPPO, demanding termination of key engineers and seizure of hardware in dramatic courtroom showdown over patent infringement allegations.
How GLP-1 Drugs Are Quietly Reshaping America's Waistline
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Semaglutide: Weight Loss Drug Protects Heart
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.
IPO Lock-In Expiry: 7 Stocks Under Scanner
Critical IPO lock-in expiry for 7 companies including Waaree Energies and SolarWorld Energy could trigger significant stock volatility. Expert analysis on what investors should expect.
Market Volatility Alert: F&O Expiry & Budget Impact
Indian markets brace for volatility as F&O expiry and interim budget approach. Banking stocks show resilience while IT faces pressure. Key technical levels to watch for Nifty and Bank Nifty.
Semaglutide Boosts Heart Health in New Study
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
SEBI Shifts Index Options Expiry to 4 PM for BSE, NSE
Major shakeup in Indian derivatives market as SEBI mandates uniform 4:00 PM expiry for index options on both BSE and NSE exchanges. Discover how this strategic shift will impact market dynamics, trading volumes, and investor opportunities.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Supreme Court allows generic SMA drug in blow to Roche
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
Ozempic May Reduce Alcohol Intoxication Sensation
New research suggests diabetes and weight loss medications like Ozempic could alter how your body processes alcohol, potentially making you feel less intoxicated. Learn what this means for users.
Page 4 of 4